Welcome to our dedicated page for NEON BLOOM news (Ticker: NBCO), a resource for investors and traders seeking the latest updates and insights on NEON BLOOM stock.
Neon Bloom, Inc. (OTC: NBCO) is a diversified holding company with investments spanning healthcare, financial services, and emerging markets. Established to capitalize on high-growth opportunities, Neon Bloom recently completed significant updates to its disclosure reports, achieving 'Current Information' status with the OTC Markets Group. This accomplishment aligns with the company's focus on compliance and transparency, further bolstered by the expertise of Fred Luke, who was appointed as Secretary and a Board member.
Neon Bloom operates through several key subsidiaries. One of its prominent holdings is Bazelet Health Systems, Inc., a pioneer in the health and wellness sector. Bazelet developed PECSA™, a patent-pending, plant-based ingredient derived from a legally patented cannabis plant known as PAN2020. This unique plant contains 0.00% THC, making it the first federally legal cannabis plant. PECSA™ is used in food, drug, and cosmetic products that comply with the U.S. Food, Drug, and Cosmetic Act.
In 2024, Bazelet is set to enter the lucrative $60 billion U.S. organic food and beverage market with its PECSA™ Organic product. This move aligns with the growing consumer demand for organic products and presents a significant growth opportunity for Neon Bloom.
Neon Bloom also continues to expand in the financial services sector. The company has signed a Letter of Intent to acquire Advanced Executive Sales, LLC (AES), a rapidly growing e-commerce and point-of-sale transaction solutions provider. This acquisition is expected to increase annual revenues by $20 million, providing immediate positive cash flow and enabling further acquisitions.
As part of its growth strategy, Neon Bloom is committed to making additional acquisitions using a combination of common stock, performance-based notes, and available cash. The company's leadership team, strengthened by experienced executives like Fred Luke, is focused on operational efficiency and strategic expansion to deliver long-term value to shareholders.
Neon Bloom Inc. (OTC: NBCO) has appointed Walter Tabaschek as Chief Operating & Financial Officer of its subsidiary, Bazelet Health Systems, Inc. Tabaschek joins from Bunge LTD., where he held significant roles, including COO of the Financial Services Group. He aims to spearhead Bazelet's operations and financial strategy, focusing on the marketing of PECSA™, a unique cannabis ingredient. Tabaschek is actively engaging investors at the Benzinga Cannabis Capital Conference, showcasing Bazelet's innovations in federally legal cannabis products.
Neon Bloom Inc. (OTC: NBCO) announces the launch of PECSA™, a first-to-market, federally legal cannabis ingredient developed by its subsidiary, Bazelet Health Systems, Inc. PECSA™, a plant-based, patent-pending ingredient, is designed for the food, drug, tobacco, and cosmetic industries and contains zero THC and CBD. It aims to support the Endocannabinoid System, potentially benefiting various health conditions. The ingredient will be supplied to enterprises interested in incorporating legal cannabinoid-derived ingredients into their products. PECSA™ is derived from the patented Pan2020 cannabis plant, ensuring compliance with federal regulations.
Neon Bloom, through its subsidiary Bazelet Health Systems, is enhancing the cannabis industry with non-psychoactive products. On January 3, 2022, the company received shareholder consent to amend its Articles of Incorporation, increasing its authorized shares to 750 million and creating 2 million shares of Series B Preferred stock. Bazelet is at the forefront of cannabis genome engineering, utilizing CRISPR technology to develop patented therapeutic plants that comply with federal regulations.
Neon Bloom (OTC: NBCO) has entered a licensing agreement with Floresta, LLC to cultivate Panakeia™ plants, unique cannabis genetics with 0.00% THC, at a facility in Tallahassee, Florida. This development positions Bazelet Health Systems, its subsidiary, to enhance its relationship with the FDA by supporting research on cannabis products. The initiative aims to contribute to FDA studies focused on the safety and efficacy of non-psychoactive cannabis. Additionally, part of the plants will support educational initiatives in cannabis research in Florida.
Bazelet Health Systems announced that its cannabis genetics excelled in Cornell University's "2021 Fiber and Dual-Purpose Strip Trials", leading in metrics like seed weight and germination rates. Notably, Bazelet's genetics had a seed weight over 20% greater than competitors and a germination rate of 88%. The varieties also reported nearly double the plant density, with heights 1.5 times taller than other strains. This success highlights Bazelet's commitment to developing non-psychoactive cannabis aimed at transforming agriculture and the food supply chain.
Bazelet Health Systems, a subsidiary of Neon Bloom (OTC:NBCO), has partnered with Sattviko to create a new line of superfoods infused with non-psychoactive cannabis ingredients. This collaboration aims to market healthy snacks that are diabetic-friendly, gluten-free, and packed with nutrients. The products will launch in the U.S. and globally in late 2021, supporting an expected growth in the superfoods market, projected to surpass $200 billion within five years. This partnership positions both companies at the forefront of the global superfood revolution.
Bazelet Research, a subsidiary of Neon Bloom (OTC: NBCO), has initiated advanced plant breeding for THC-Free cannabis cultivars aimed at regional adaptation in the Southeast U.S. The goal is to create safe 0.00% THC strains for the legal hemp market. The company boasts a 15,000 sf plant tissue culture lab and utilizes cutting-edge CRISPR gene-editing technology. Supported by the USDA, this initiative aims to enhance plant production and sustainable agriculture, addressing emerging demands in various industries.
Bazelet Oglesby, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has partnered with Mobile Hemp Drying Company (MHD) to enhance its Plant Science Service Plan. This collaboration will provide premium post-harvest hemp drying services utilizing advanced LMC Manufacturing equipment. MHD's system is designed to maintain optimal cannabinoid integrity during the drying process. CEO Ryan Kelly praised Bazelet's advancements in the hemp industry, while Bazelet’s Director, Kirk Calvert, highlighted the benefits of this service in terms of cost savings and risk reduction for customers.
Neon Bloom, Inc. (OTC: NBCO) announced on April 16, 2021, that Bazelet Oglesby has successfully planted its patented 0.00% THC Panakeia cannabis plants in South Georgia. This development marks Bazelet's entry into the Georgia cannabis market, utilizing a former golf course for crop production. Panakeia is the world's first patented cannabis plant with zero THC, making it compliant with federal law. Bazelet aims to provide safe and effective cannabinoid products for healthcare professionals, particularly as Georgia launches a low THC medical marijuana program.
Bazelet Health Systems, a subsidiary of Neon Bloom, Inc. (OTC: NBCO), has appointed Dr. Francisco Ward as its new Chief Medical Officer. Dr. Ward, a graduate of Johns Hopkins School of Medicine, brings over 25 years of medical expertise and leadership, particularly in the endocannabinoid system and medical cannabis. He is tasked with overseeing Bazelet's healthcare programs, clinical research, and patient experience standards from the Columbia, Maryland office. His appointment emphasizes Bazelet's commitment to effective medical treatment through advanced research and patient-centered care.
FAQ
What is the current stock price of NEON BLOOM (NBCO)?
What is the market cap of NEON BLOOM (NBCO)?
What is Neon Bloom, Inc.?
Who are Neon Bloom's key executives?
What is PECSA™?
What recent acquisitions has Neon Bloom made?
What are Neon Bloom's plans for the organic market?
How does Neon Bloom plan to fund its acquisitions?
What is the significance of PAN2020?
How did Neon Bloom achieve 'Current Information' status?
What are the expected financial impacts of acquiring AES?
What industries does Neon Bloom invest in?
